Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study reveals hidden risks in Kids' airway devices

NCT ID NCT06073977

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 3,750 children aged 1-12 to find out why placing a supraglottic airway device (a type of breathing tube) can be difficult. The goal was to identify risk factors like the doctor's experience or the child's health history. The study did not test any new treatment, but aimed to improve safety by understanding these challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

3,750 people

The number who actually took part.

Started

Oct 2023

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1- 12 years old peditatric patients scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance

Ages

1 year to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1- 12 years old peditatric patients * ASA class I- III * Planned surgery under general anesthesia with supraglottic airway * Patients whose legal guardians provide informed consent Exclusion Criteria: * Refusal to participate in the study * Inability of patient or parents to understand the study or consent process * Orotracheal intubation requirement * Pathology of airway, neck, respiratory tract, upper gastrointestinal tract * Increased risk of regurgitation or aspiration * Emergency surgeries * Requirement for intensive care follow-up after the surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asli Dönmez

    Ankara, Turkey (Türkiye)

  • Emre Sertaç Bingül

    Istanbul, Turkey (Türkiye)

  • Gaye Aydin

    Izmir, Turkey (Türkiye)

  • Necmettin Erbakan University

    Konya, Turkey (Türkiye)

  • Sedat Saylan

    Trabzon, Turkey (Türkiye)

  • Sibel Seçkin Pehlivan

    Kayseri, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.